Biologic Battlefields: Changes in the US Markets for Rheumatoid Arthritis and Psoriatic Arthritis

Author：

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.1, Iss.3, 2004-01, pp. : 16-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic Therapy in Rheumatoid Arthritis

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. : 752-759

Bentham Science Publishers

Access to resources Recommend Favorite

Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis

By Tilling Lindsey Townsend Sue David Joel

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 55-62

Adis International

Access to resources Recommend Favorite

Biologic Agents for Treatment of Rheumatoid Arthritis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 1, 2010-03 ,pp. : 8-23

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Agents in the Treatment of Rheumatoid Arthritis

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 3, 2000-11 ,pp. : 217-233

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond methotrexate: biologic therapy in rheumatoid arthritis

By Ostör Andrew J

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 222-226

Royal College Of Physicians

Access to resources Recommend Favorite